company background image
IQAI logo

IQ-AI LSE:IQAI Stock Report

Last Price

UK£0.016

Market Cap

UK£3.5m

7D

10.3%

1Y

-56.2%

Updated

13 Dec, 2024

Data

Company Financials

IQAI Stock Overview

Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. More details

IQAI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

IQ-AI Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for IQ-AI
Historical stock prices
Current Share PriceUK£0.016
52 Week HighUK£0.051
52 Week LowUK£0.0093
Beta2.4
1 Month Change45.45%
3 Month Change33.33%
1 Year Change-56.16%
3 Year Change-72.77%
5 Year Change-65.96%
Change since IPO-55.86%

Recent News & Updates

Recent updates

IQ-AI (LON:IQAI) Is In A Good Position To Deliver On Growth Plans

Feb 08
IQ-AI (LON:IQAI) Is In A Good Position To Deliver On Growth Plans

Have IQ-AI Limited (LON:IQAI) Insiders Been Selling Their Stock?

Dec 09
Have IQ-AI Limited (LON:IQAI) Insiders Been Selling Their Stock?

Shareholder Returns

IQAIGB Healthcare ServicesGB Market
7D10.3%1.4%-0.2%
1Y-56.2%21.3%6.9%

Return vs Industry: IQAI underperformed the UK Healthcare Services industry which returned 26.1% over the past year.

Return vs Market: IQAI underperformed the UK Market which returned 6.2% over the past year.

Price Volatility

Is IQAI's price volatile compared to industry and market?
IQAI volatility
IQAI Average Weekly Movement10.5%
Healthcare Services Industry Average Movement5.0%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.5%
10% least volatile stocks in GB Market2.6%

Stable Share Price: IQAI's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: IQAI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
19657Trevor Brownwww.iqai.ltd

IQ-AI Limited, through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018.

IQ-AI Limited Fundamentals Summary

How do IQ-AI's earnings and revenue compare to its market cap?
IQAI fundamental statistics
Market capUK£3.55m
Earnings (TTM)-UK£597.65k
Revenue (TTM)UK£770.99k

4.6x

P/S Ratio

-5.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IQAI income statement (TTM)
RevenueUK£770.99k
Cost of RevenueUK£9.64k
Gross ProfitUK£761.34k
Other ExpensesUK£1.36m
Earnings-UK£597.65k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0027
Gross Margin98.75%
Net Profit Margin-77.52%
Debt/Equity Ratio0%

How did IQAI perform over the long term?

See historical performance and comparison